eNavvi and Cost Plus Drugs Expand Relationship to Enhance Prescription Access | PR Newswire [Video]

, /PRNewswire/ — eNavvi, Inc., a leader in the prescription marketplace, and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) are excited to announce a strategic collaboration that enables physicians to prescribe medications directly through eNavvi’s digital prescription pad to over 7,000 independent pharmacies and major national grocery pharmacy chains. This relationship streamlines the prescribing process, improves convenience, and enhances prescription price transparency for patients nationwide.

Revolutionizing Prescription Access

Through this integration, physicians can use eNavvi’s platform to compare medication prices in real-time and prescribe directly from eNavvi with just a few clicks. Patients now have the option to pick up their prescriptions from local pharmacies, offering greater convenience and faster access especially for time sensitive prescriptions.

“Our expansion into the retail pharmacy sector exemplifies our commitment to simplifying the prescribing process for physicians and patients,” said Simon Chang, DO, CEO of eNavvi. “By expanding with Cost Plus Drugs and integrating with major grocery …